National Cancer Institute; Notice of Closed Meetings, 59811-59812 [2020-20993]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 185 / Wednesday, September 23, 2020 / Notices
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kee Forbes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7806, Bethesda, MD 20892, (301) 272–
4865, pyonkh2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 17, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–20944 Filed 9–22–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–8:
Research Answers to NCI Provocative
Questions.
Date: October 27, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Shree Ram Singh, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248, Rockville, MD
20850, 240–276–5735, singhshr@
mail.nih.gov.
VerDate Sep<11>2014
18:02 Sep 22, 2020
Jkt 250001
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–7: NCI
Clinical and Translational R21 and Omnibus
R03 Review.
Date: October 29, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W242, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Rockville, MD
20850, 240–276–6372, zouzhiq@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Strengthening Capacity for Global Research
in Low- and Middle-Income Countries.
Date: October 30, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W624, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Timothy C. Meeker, M.D.,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W624,
Rockville, MD 20850, 240–276–6464,
meekert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Integrating
Biospecimen Science Approaches into
Clinical Assay Development (U01).
Date: November 6, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W606, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Timothy C. Meeker, M.D.,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W606,
Rockville, MD 20850, 240–276–6464,
meekert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Provocative
Questions in Cancer with an Underlying HIV
Infection.
Date: November 10, 2020.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W634, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Michael E. Lindquist,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W634, Rockville, MD 20850, 240–
276–5735, mike.lindquist@nih.gov.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
59811
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–5: NCI
Clinical and Translational R21 and Omnibus
R03 Review.
Date: November 12, 2020.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W244, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: John Paul Cairns, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W244,
Rockville, MD 20850, 240–276–5415,
paul.cairns@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SBIR Phase
IIB Bridge Awards.
Date: November 17, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Anita T. Tandle, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W248,
Rockville, MD 20850, 240–276–5085,
tandlea@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–5:
Research Answers to NCI Provocative
Questions.
Date: November 19, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W602, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Delia Tang, M.D.,
Scientific Review Officer, Resources Training
and Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W602,
Rockville, MD 20892, 240–276–6456, tangd@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–4:
Research Answers to NCI Provocative
Questions.
Date: December 10, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W120, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Dr., Room 7W120,
Rockville, MD 20850, 240–276–6457,
mh101v@nih.gov.
E:\FR\FM\23SEN1.SGM
23SEN1
59812
Federal Register / Vol. 85, No. 185 / Wednesday, September 23, 2020 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 17, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–20993 Filed 9–22–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Cancer Genetics Study Section.
Date: October 22–23, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Juraj Bies, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301–435–1256, biesj@mail.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Vaccines Against
Microbial Diseases Study Section.
Date: October 22–23, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Wang, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
VerDate Sep<11>2014
18:02 Sep 22, 2020
Jkt 250001
MSC 7812, Bethesda, MD 20892, (301) 435–
2778, wangjia@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Respiratory Integrative Biology and
Translational Research Study Section.
Date: October 22–23, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bradley Nuss, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7814, Bethesda, MD 20892, 301–451–
8754, nussb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Bacterial Pathogenesis.
Date: October 22, 2020.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard G. Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 240–519–
7808, kostrikr@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Hypersensitivity,
Autoimmune, and Immune-mediated
Diseases Study Section.
Date: October 22–23, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4207,
MSC 7812, Bethesda, MD 20892, (301) 435–
1238, hodged@mail.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Drug Discovery for the
Nervous System Study Section.
Date: October 22–23, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mary Custer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7850, Bethesda, MD 20892, (301) 435–
1164, custerm@csr.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Hemostasis and Thrombosis Study Section.
Date: October 22, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Tobacco Regulatory Science B.
Date: October 23, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weijia Ni, Ph.D., Chief/
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100,
MSC 7808, Bethesda, MD 20892, 301–594–
3292, niw@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Research
Enhancement Award: Surgical Sciences,
Biomedical Imaging, and Bioengineering.
Date: October 23, 2020.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Inna Gorshkova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–435–1784, gorshkoi@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 17, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–20992 Filed 9–22–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 85, Number 185 (Wednesday, September 23, 2020)]
[Notices]
[Pages 59811-59812]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20993]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-8: Research Answers to NCI Provocative Questions.
Date: October 27, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W248, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Shree Ram Singh, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W248, Rockville, MD 20850, 240-276-5735, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-7: NCI Clinical and Translational R21 and Omnibus R03
Review.
Date: October 29, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W242, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Rockville, MD 20850, 240-276-6372, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Strengthening Capacity for Global Research in Low- and
Middle-Income Countries.
Date: October 30, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W624, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Timothy C. Meeker, M.D., Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W624, Rockville, MD 20850, 240-276-6464,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Integrating Biospecimen Science Approaches into Clinical
Assay Development (U01).
Date: November 6, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W606, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Timothy C. Meeker, M.D., Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W606, Rockville, MD 20850, 240-276-6464,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Provocative Questions in Cancer with an Underlying HIV
Infection.
Date: November 10, 2020.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W634, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Michael E. Lindquist, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W634, Rockville, MD 20850, 240-276-5735,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-5: NCI Clinical and Translational R21 and Omnibus R03
Review.
Date: November 12, 2020.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W244, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: John Paul Cairns, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W244, Rockville, MD 20850, 240-276-5415,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SBIR Phase IIB Bridge Awards.
Date: November 17, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W248, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Anita T. Tandle, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W248, Rockville, MD 20850, 240-276-5085,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-5: Research Answers to NCI Provocative Questions.
Date: November 19, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W602, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Delia Tang, M.D., Scientific Review Officer,
Resources Training and Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W602, Rockville, MD 20892, 240-276-6456,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-4: Research Answers to NCI Provocative Questions.
Date: December 10, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W120, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Majed M. Hamawy, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center Dr.,
Room 7W120, Rockville, MD 20850, 240-276-6457, [email protected].
[[Page 59812]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 17, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-20993 Filed 9-22-20; 8:45 am]
BILLING CODE 4140-01-P
